Status:
TERMINATED
Effects of Gabapentin in the Treatment of Neuropathic Pain on Driving Performance and Cognition
Lead Sponsor:
UMC Utrecht
Collaborating Sponsors:
Utrecht University
Conditions:
Chronic Neuropathic Pain
Eligibility:
All Genders
30-60 years
Phase:
PHASE4
Brief Summary
The aim of this study was to explore the effects of pain on the one hand and the effects of treatment of pain with gabapentin (900, 1200, 1800 or 2400 mg) on the other hand on actual driving performan...
Detailed Description
Numerous studies demonstrate neuropsychological impairment in patients with chronic pain, particularely on measures assessing attentional capacity, processing speed and psychomotor speed. About 50% of...
Eligibility Criteria
Inclusion
- age, responder to gabapentin,succesfully treated with gabapentin at least 4 weeks before start of study, minimal VAS pain intensity scores of 4 cm on a 10 cm scale, driving licence, driving experience, fluently speaking Dutch, normal vision, right-handed
Exclusion
- alcohol- or drug dependence, use of other psychotropic medication, use of illicit drugs, psychological or physical disorder other than pain or pain-related, excessive smoking and drinking
Key Trial Info
Start Date :
April 1 2003
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00189072
Start Date
April 1 2003
Last Update
September 16 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Utrecht
Utrecht, Utrecht, Netherlands, 3508 TB